Biyolojik Yaş Testi: Gerçekten Kaç Yaşındasınız?

Epigenetic tests range from $249 to $499 per test. Blood biomarker services like InsideTracker cost $200–$600. Standard blood work with a PhenoAge calculator costs $50–$150 and is often partially covered by insurance. Epigenetic tests like TruDiagnostic accept HSA/FSA payments.

Research shows biological age can be slowed and potentially reduced through lifestyle interventions. The CALERIE randomized controlled trial demonstrated that caloric restriction slowed the pace of aging measured by DunedinPACE. A pilot study showed potential epigenetic age reversal through combined diet and lifestyle interventions. Exercise studies show reductions of up to two years in epigenetic age after just eight weeks of training. However, dramatic "age reversal" claims should be viewed skeptically—the evidence supports modest improvements, not turning back the clock by decades.

Every 6–12 months if you're actively tracking interventions, or annually for general monitoring. Testing more frequently than every 6 months is generally not useful because short-term fluctuations can obscure real changes, and the costs add up. Establish a baseline first, then implement lifestyle changes for at least 6 months before retesting.

No, biological age tests are not currently covered by health insurance. They are considered research tools, not diagnostic medical tests. However, many epigenetic testing companies accept HSA and FSA payments. Standard blood work (which can be used with PhenoAge calculators) is often partially covered by insurance.

Epigenetic age measures DNA methylation patterns that change with aging and strongly predicts mortality and disease. Telomere length measures the protective caps on chromosomes that shorten with cell division. Epigenetic clocks are significantly more accurate and predictive than telomere length tests, which have high variability and are heavily influenced by genetics. Most longevity researchers now favor epigenetic testing over telomere testing.

The evidence for supplements reducing biological age is limited and mostly experimental. NAD+ boosters (NR, NMN) increase NAD+ levels in human studies but their effect on epigenetic age is unclear. Metformin is being studied in the TAME trial. Lifestyle interventions—diet, exercise, sleep, stress management—have far stronger evidence for slowing biological aging than any supplement currently available.

GrimAge is a DNA methylation-based epigenetic clock specifically trained to predict mortality. It consistently outperforms all other epigenetic clocks for predicting time-to-death, cardiovascular disease, cancer, and frailty. GrimAge2 (2024) further improved predictions across multiple racial and ethnic groups. It's considered the most clinically relevant clock for longevity tracking because it directly measures what matters most—your risk of dying.

No. The lifestyle interventions that reduce biological age—healthy diet, regular exercise, adequate sleep, stress management, not smoking—benefit everyone regardless of testing. Testing provides motivation and tracking capability, but the interventions work whether you measure their effects or not. If cost is a concern, skip the test and invest in the lifestyle changes.

DunedinPACE measures your current pace of aging—how fast you're aging per calendar year—rather than estimating a static biological age. A score of 1.0 means average pace, below 1.0 means aging slower, above 1.0 means faster. It was validated in the CALERIE trial and is particularly useful for tracking whether interventions are changing your aging rate in real time.

Most experts suggest considering testing after age 40–50, when age-related changes become more pronounced and tracking becomes more meaningful. Younger, healthy individuals are generally aging slowly and testing won't change the basic recommendation to maintain healthy habits. The exception is people with strong family histories of age-related diseases who may benefit from earlier baseline testing.

Different epigenetic clocks are trained on different outcomes using different algorithms. Horvath was trained to predict chronological age across tissues, PhenoAge predicts phenotypic aging, GrimAge predicts mortality. Each captures a different dimension of the aging process. This is normal and expected—no single number perfectly represents biological age. When tracking over time, use the same test consistently for valid comparisons.